Popular Articles

HeartWorks Simulation - A Breakthrough In Education For Cardiothoracic Anesthesiologists
The world"s first virtual heart has been developed to improve teaching of peri-operative transesophageal echocardiography (TEE) skills in the care of patients with heart disease. HeartWorks, a uniquely realistic computer-generated model of the heart and echocardiography simulator, is the result of a 4 year project driven by a team of three London-based cardiac anaesthesiologists. Recognising the power of education through simulation and its increasingly widespread adoption throughout clinical practice, the team is spearheading a pathway change in education in one of the most interesting and challenging areas of cardiac care. Now in production by Inventive Medical, a subsidiary of UCLH Charity London, HeartWorks is set to dramatically transform TEE training by university teaching hospitals worldwide.

National Pharmacy Association Project To Improve NHS Commissioning, UK
The NPA is working with LPCs and PCTs to develop a process for assuring the quality of commissioning of community pharmacy services. The aim of the project is to increase constructive dialogue between contractors and commissioners, increase the level of local investment in pharmacy services and improve PCT performance right the way around the commissioning cycle.
News of the day
Massachusetts Officials Issue Directive That Seeks To Streamline HIV Testing Consent Process
The Massachusetts Department of Public Health yesterday issued a directive recommending that health care providers include written consent for HIV testing in the general permission forms given to patients receiving medical care, the Boston Globe reports. State health care providers typically give patients separate consent forms for HIV testing, a practice health officials say poses as a barrier to HIV testing for patients and their providers. The new Massachusetts recommendation states that HIV testing should be explicitly mentioned on standard general consent forms. Reinforcing a provision in the CDC"s 2006 HIV testing guidelines, the directive also recommends routine HIV testing for all residents age 13 to 64 in health care settings. Patients in Massachusetts must still opt in to HIV testing, whereas the CDC recommends that HIV testing be performed unless a patient opts out, according to the Globe (Cooney, Boston Globe, 6/25).
Oncology

Therapeutic Contact Lenses And Patients' Own Stem Cells Used To Rehabilitate Damaged Eye Surfaces

In a world-first breakthrough, University of New South Wales (UNSW) medical researchers have used stem cells cultured on a simple contact lens to restore sight to sufferers of blinding corneal disease. Sight was significantly improved within weeks of the procedure, which is simple, inexpensive and requires a minimal hospital stay. The research team from UNSW"s School of Medical Sciences harvested stem cells from patients" own eyes to rehabilitate the damaged cornea. The stem cells were cultured on a common therapeutic contact lens which was then placed onto the damaged cornea for 10 days, during which the cells were able to re-colonise the damaged eye surface. While the novel procedure was used to rehabilitate damaged corneas, the researchers say it offers hope to people with a range of blinding eye conditions and could have applications in other organs. A paper detailing the breakthrough appears in the high-impact journal Transplantation this week. The trial was conducted on three patients; two with extensive corneal damage resulting from multiple surgeries to remove ocular melanomas, and one with the genetic eye condition aniridia. Other causes of cornea damage can include chemical or thermal burns, bacterial infection and chemotherapy. "The procedure is totally simple and cheap," said lead author of the study, UNSW"s Dr Nick Di Girolamo. "Unlike other techniques, it requires no foreign human or animal products, only the patient"s own serum, and is completely non-invasive. "There"s no suturing, there is no major operation: all that"s involved is harvesting a minute amount - less than a millimeter - of tissue from the ocular surface," Dr Di Girolamo said. "If you"re going to be treating these sorts of diseases in third world countries all you need is the surgeon and a lab for cell culture. You don"t need any fancy equipment." Because the procedure uses the patient"s own stem cells harvested from their eye, it is ideal for sufferers of unilateral eye disease. However, it also works in patients who have had both eyes damaged, Dr Di Girolamo said. "One of our patients had aniridia, a congenital condition affecting both eyes. In that case, instead of taking the stem cells from the other cornea, we took them from another part of the eye altogether - the conjunctiva - which also harbours stem cells. "The stem cells were able to change from the conjunctival phenotype to a corneal phenotype after we put them onto the cornea. That"s the beauty of stem cells," Dr Di Girolamo said. The therapeutic contact lens used in the trial was of a type commonly used worldwide after ocular surface surgery. However, of the several brands on the market, only one was suitable for growing the stem cells. "We don"t know why. It"s probably to do with the components the manufacturers have used in that particular lens," Dr Di Girolamo said. The researchers are hopeful the technique can be adapted for use in other parts of the eye, such as the retina, and even in other organs. "If we can do this procedure in the eye, I don"t see why it wouldn"t work in other major organs such as the skin, which behaves in a very similar way to the cornea," Dr Di Girolamo said. Dr Di Girolamo"s team included UNSW medical scientists Professor Denis Wakefield and Dr Stephanie Watson. Steve Offner University of New South Wales


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):